FMS News and Press, Fresenius Medical Care AG From 08/30/22

Fresenius Medical Care Wins Major Award to Support U.S. Veterans with Industry-Leading Dialysis Care PR Newswire The Department of Veterans Affairs Approves Purchase of FMCNA Products in Five Categories WALTHAM, Mass. , Aug. 30, 2022 /PRNewswire/ ...

Summary Tweedy, Browne’s 13F portfolio value decreased from $3.10B to $2.45B this quarter. They added FedEx Corp., American Express, and Paramount Global while decreasing AutoZone and dropping 3M. Alphabet at ~18% of the portfolio is the largest position. This...

German health services company Fresenius Medical Care AG & Co. ( NYSE: FMS ) ( OTCPK:FMCQF ) announced Friday that the head of its pharmaceutical division Michael Sen would become the company’s new Chief Executive effective Oct. 01. Sen will replace Freseniu...

The Swiss Agency for Therapeutic Products (Swissmedic) approved Cara Therapeutics ( NASDAQ: CARA ) and Vifor Fresenius Medical Care Renal Pharma's Kapruvia (difelikefalin) to treat moderate-to-severe pruritus (itching) associated with chronic kidney disease ...

The shares of Fresenius, one of the world's largest healthcare groups, have been in a downward and then a sideways trend since 2017. Corona pandemic has been a major challenge, especially for its subsidiary Fresenius Medical Care. Despite further waves of infection, the worst of the c...

Vifor Fresenius Medical Care Renal Pharma said that England's National Institute for Health and Care Excellence (NICE) recommended Tavneos in combination with a rituximab or cyclophosphamide regimen to treat adult patients with severe, active granulomatosis polyangiitis (GPA)...

Inflation and the better than feared earnings season dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. Inflation is softening in July and markets have started to rally again. U...

CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms PR Newswire Fresenius Medical Care and CytoSorbents have expanded their partnership via a multi-stage collaboration designed to seize new sales opportunitie...

Fresenius isn't just an undervalued aristocrat, it's a Buffett-style anti-bubble "fat pitch" that could deliver 235% returns in the next five years. Even with the Pandemic-induced downturn, FMS is expected to grow at 12% CAGR through 2027. If FMS grows as analysts expect by 2024 a...

Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...